Introduction
Adverse effects due to beta-blockers may be predictable according to their known pharmacological properties or may be unpredictable. The latter include the oculo-muco-cutaneous syndrome with practolol and the high titres of antinuclear and other auto-antibodies and LE cells with practolol and acebutolol.1 Although parasthesiae as well as nerve deafness were mentioned among the side effects,2 to the best of our knowledge, there has been no report of the carpal tunnel syndrome (CTS).
We report here an association between prolonged beta-blocker therapy and the occurrence of CTS in three hypertensive men.
Patients
The first patient, aged 58 4 A few drugs have been suspected of causing it by different mechanisms.5 Oral contraceptives, danazol and progesterone may act by leading to oedema as a result of fluid retention, thalidomide and disulfiram act by producing a peripheral neuropathy.5 CTS had been associated with pyridoxine deficiency, which when given in large doses produced marked improvement with avoidance of surgery in some cases.6 Pyridoxine deficiency might lead to CTS not only by producing peripheral neuropathy, but also by leading to synovial subendothelial oedema with proliferative and fibrotic changes.7 The andidepressant tranylcypromine was thought to lead to the syndrome by impairing pyridoxine metabolism. 8 The association of CTS with pyridoxine deficiency was, however, questioned in other studies. 9 The relationship between prolonged beta-blocker therapy and the development of CTS is suggested by the disappearance of all symptoms and signs after withdrawal of the drug. The mechanism of this association is not clear to us. It may result from fluid retention and oedema secondary to betablocker therapy.2 The presence of a latent peripheral neuropathy, or of proximal compression might make the nerve vulnerable to lesser degrees of pressure at the wrist 'double crush'.10 There was no evidence of any of these complications in our patients. Pyridoxine deficiency however could not be excluded because the appropriate laboratory tests were not available.
Beta-blockers may lead to peripheral vasospasm and an association has been reported between this and CTS, but the vasospasm was thought to be due to pressure over the autonomic fibres in the nerve.'1 Moreover none of our patients had any symptoms or signs suggestive of peripheral vasospasm. We believe that this association needs further documentation. All our patients on long term beta-blocker therapy are being asked now about symptoms suggestive of CTS, in a more extensive study.
